Cargando…

Current Landscape of NRF2 Biomarkers in Clinical Trials

The transcription factor NF-E2 p45-related factor 2 (NRF2; encoded by NFE2L2) plays a critical role in the maintenance of cellular redox and metabolic homeostasis, as well as the regulation of inflammation and cellular detoxication pathways. The contribution of the NRF2 pathway to organismal homeost...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yagishita, Yoko, Gatbonton-Schwager, Tonibelle N., McCallum, Melissa L., Kensler, Thomas W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464243/ https://www.ncbi.nlm.nih.gov/pubmed/32784785 http://dx.doi.org/10.3390/antiox9080716

Ejemplares similares

A Point Mutation at C151 of Keap1 of Mice Abrogates NRF2 Signaling, Cytoprotection in Vitro, and Hepatoprotection in Vivo by Bardoxolone Methyl (CDDO-Me)
por: Gatbonton-Schwager, Tonibelle, et al.
Publicado: (2023)

Constitutive Activation of Nrf2 in Mice Expands Enterogenesis in Small Intestine Through Negative Regulation of Math1
por: Yagishita, Yoko, et al.
Publicado: (2020)

NRF2 and the Moirai: Life and Death Decisions on Cell Fates
por: Yagishita, Yoko, et al.
Publicado: (2023)

SUN-LB101 NRF2 Represses Obesity-Associated Adipose Tissue Inflammation in Mice
por: Yagishita, Yoko, et al.
Publicado: (2020)

Identification of a negative feedback loop in biological oxidant formation fegulated by 4-hydroxy-2-(E)-nonenal
por: Gatbonton-Schwager, Tonibelle N., et al.
Publicado: (2014)

Forced Hepatic Expression of NRF2 or NQO1 Impedes Hepatocyte Lipid Accumulation in a Lipodystrophy Mouse Model
por: Wakabayashi, Nobunao, et al.
Publicado: (2023)

Chromosomal Mcm2-7 distribution and the genome replication program in species from yeast to humans
por: Foss, Eric J., et al.
Publicado: (2021)

Sir2 suppresses transcription-mediated displacement of Mcm2-7 replicative helicases at the ribosomal DNA repeats
por: Foss, Eric J., et al.
Publicado: (2019)

Perturbed maintenance of transcriptional repression on the inactive X-chromosome in the mouse brain after Xist deletion
por: Adrianse, Robin L., et al.
Publicado: (2018)

Broccoli or Sulforaphane: Is It the Source or Dose That Matters?
por: Yagishita, Yoko, et al.
Publicado: (2019)

Novel NRF2‐activated cancer treatments utilizing synthetic lethality
por: Baird, Liam, et al.
Publicado: (2022)

Telomere Length as a Quantitative Trait: Genome-Wide Survey and Genetic Mapping of Telomere Length-Control Genes in Yeast
por: Gatbonton, Tonibelle, et al.
Publicado: (2006)

Correction: Telomere Length as a Quantitative Trait: Genome-Wide Survey and Genetic Mapping of Telomere Length-Control Genes in Yeast
por: Gatbonton, Tonibelle, et al.
Publicado: (2006)

NRF2 as an Emerging Therapeutic Target
por: Copple, Ian M., et al.
Publicado: (2017)

Keap1/Nrf2 pathway in the frontiers of cancer and non-cancer cell metabolism
por: Chartoumpekis, Dionysios V., et al.
Publicado: (2015)

KEAP1 and done? Targeting the NRF2 pathway with sulforaphane
por: Dinkova-Kostova, Albena T., et al.
Publicado: (2017)

Wildlife disease ecology in changing landscapes: Mesopredator release and toxoplasmosis
por: Hollings, Tracey, et al.
Publicado: (2013)

New Player on An Old Field; the Keap1/Nrf2 Pathway as a Target for Treatment of Type 2 Diabetes and Metabolic Syndrome
por: Chartoumpekis, Dionysios V, et al.
Publicado: (2013)

Genomic and proteomic biomarker landscape in clinical trials
por: Piñero, Janet, et al.
Publicado: (2023)

The Challenges of Designing and Implementing Clinical Trials With Broccoli Sprouts… and Turning Evidence Into Public Health Action
por: Fahey, Jed W., et al.
Publicado: (2021)

Diabetic gastroparesis: current challenges and future prospects
por: Avalos, Danny J, et al.
Publicado: (2018)

Pseudoachalasia: Still a Tough Clinical Challenge
por: Jia, Yi, et al.
Publicado: (2015)

The Current Landscape of Clinical Trials for Systemic Treatment of HCC
por: Foerster, Friedrich, et al.
Publicado: (2021)

A NRF2-induced secretory phenotype activates immune surveillance to remove irreparably damaged cells
por: Baird, Liam, et al.
Publicado: (2023)

The Current Landscape of Glioblastoma Biomarkers in Body Fluids
por: Zanganeh, Saba, et al.
Publicado: (2023)

Molecular landscape of pancreatic cancer: implications for current clinical trials
por: Heestand, Gregory M., et al.
Publicado: (2015)

Pharmacogenomics of Chemically Distinct Classes of Keap1-Nrf2 Activators Identify Common and Unique Gene, Protein, and Pathway Responses In Vivo
por: Wible, Ryan S., et al.
Publicado: (2018)

Glycogen Synthase Kinase-3: A Focal Point for Advancing Pathogenic Inflammation in Depression
por: McCallum, Ryan T., et al.
Publicado: (2021)

NRF2 regulates core and stabilizing circadian clock loops, coupling redox and timekeeping in Mus musculus
por: Wible, Ryan S, et al.
Publicado: (2018)

The Current Landscape of Targeted Clinical Trials in Non-WNT/Non-SHH Medulloblastoma
por: Ghasemi, David R., et al.
Publicado: (2022)

Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice
por: Rangasamy, Tirumalai, et al.
Publicado: (2005)

Scoping review of the current landscape of AI-based applications in clinical trials
por: Cascini, Fidelia, et al.
Publicado: (2022)

Astatine-211 based radionuclide therapy: Current clinical trial landscape
por: Albertsson, Per, et al.
Publicado: (2023)

The Current Clinical Trial Landscape for Hidradenitis Suppurativa: A Narrative Review
por: Hunt, Amanda, et al.
Publicado: (2023)

Pharmacologic modulation of motility.
por: McCallum, R. W.
Publicado: (1999)

Introduction to Symposium on “Gastrointestinal Manifestations of Diabetes Mellitus”
por: McCallum, Richard W.
Publicado: (1983)

Letter to the Editor from R. McCallum: “Weight Loss From Combination Anti-Obesity Medication Regimens Can Approach That Achieved From Bariatric Surgery”
por: McCallum, Roland W
Publicado: (2023)

Analgesic Efficacy and Safety of Intravenous Meloxicam in Subjects With Moderate-to-Severe Pain After Open Abdominal Hysterectomy: A Phase 2 Randomized Clinical Trial
por: Rechberger, Tomasz, et al.
Publicado: (2019)

The tumor mutational landscape of BRCA2-deficient primary and metastatic prostate cancer
por: Kensler, Kevin H., et al.
Publicado: (2022)

Biomarkers: Opportunities and Challenges for Drug Development in the Current Regulatory Landscape
por: Gromova, Mariya, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vpp4ik0hqv73k5eg009sfrneea